Cleared Special

K232737 - PowerPort™ ClearVUE™ Slim ECG Enabled Implantable Port (FDA 510(k) Clearance)

Also includes:
PowerPort™ ClearVUE™ isp ECG Enabled Implantable Port PowerPort™ isp M.R.I.™ ECG Enabled Implantable Port PowerPort™ Slim ECG Enabled Implantable Port
Dec 2023
Decision
92d
Days
Class 2
Risk

K232737 is an FDA 510(k) clearance for the PowerPort™ ClearVUE™ Slim ECG Enabled Implantable Port. This device is classified as a Port & Catheter, Implanted, Subcutaneous, Intravascular (Class II - Special Controls, product code LJT).

Submitted by Bard Peripheral Vascular, Inc. (Tempe, US). The FDA issued a Cleared decision on December 8, 2023, 92 days after receiving the submission on September 7, 2023.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5965.

Submission Details

510(k) Number K232737 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 07, 2023
Decision Date December 08, 2023
Days to Decision 92 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code LJT — Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5965